Magnolia Neurosciences Receives $20 Million CPRIT Grant to Develop Therapies to Treat Chemotherapy-Induced Neurological Conditions

Magnolia Neurosciences Receives $20 Million CPRIT Grant to Develop Therapies to Treat Chemotherapy-Induced Neurological Conditions

Source: 
CP Wire
snippet: 

Magnolia Neurosciences Corporation (Magnolia) announced on 8/27/18 that Korysso Therapeutics, Inc. (DBA: Magnolia Tejas Corporation), the company’s wholly owned, Houston-based subsidiary, has been awarded a $19.95 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to fund the development of a novel targeted therapy for the treatment of neurological conditions caused by chemotherapy.